Bridging Data, AI, and Scientific Trust to Accelerate Discovery.
In the high-stakes world of pharmaceutical research, access to reliable, context-rich scientific evidence can mean the difference between breakthrough therapies and costly development setbacks. Founded in 2006 and headquartered in Henderson, Nevada, Research Solutions (NASDAQ: RSSS) has emerged as a leading vertical SaaS and AI company dedicated to simplifying research workflows for academic institutions, life sciences companies, and research organizations worldwide. Today, over 85 percent of the top 20 life sciences companies and more than 70 percent of the top 20 universities rely on Research Solutions to streamline discovery, manage knowledge, and accelerate innovation.
At the heart of Research Solutions’ mission is Scite, a revolutionary tool designed to tackle one of the most persistent challenges in research: understanding citation context. In pharmaceutical development, where every data-driven decision can affect patient outcomes, Scite empowers researchers to differentiate between citations that support a finding, contrast it, or merely reference it. This clarity is crucial during early-stage drug discovery, where overlooking contradictory evidence can lead to wasted resources, delayed timelines, or even patient risk.
Research Solutions operates as one of the few publisher-independent marketplaces for scientific, technical, and medical content, combining AI-powered tools, including an intelligent research assistant and full-text search capabilities, with seamless access to both open-access and paywalled literature. By unifying discovery, access, management, and analysis in a single platform, Research Solutions enables researchers to move beyond fragmented data sources, engage deeply with evidence, and make timely, informed decisions.
Scite: Giving Researchers Clarity in a Complex World.
In the world of scientific research, every citation tells a story, and understanding that story can change the course of a discovery. Scite helps researchers see the full picture, showing whether a study supports, contradicts, or simply mentions a finding. By analyzing billions of citation statements across millions of articles, Scite turns scattered information into meaningful insights, helping teams make confident, informed decisions.
Transforming Citation Analysis.
Traditional citation databases often treat every reference the same, ignoring the nuance behind how a study is cited. Scite’s Smart Citations go beyond simple counts, analyzing full-text scholarly documents to extract “citation statements” that are then classified as supporting, contrasting, or mentioning the cited work. This approach provides researchers with instant insight into how studies are interpreted across the scientific community. To date, Scite has processed over 1.3 billion citation statements from more than three million articles across multiple disciplines.
The practical implications for pharmaceutical research are profound. Early-phase decisions from selecting therapeutic targets to designing preclinical studies,require a thorough understanding of existing evidence. Scite’s Smart Citations allow teams to identify conflicting findings, validate hypotheses, and allocate resources efficiently. Enterprise dashboards support oversight at scale, helping teams track citation trends, assess research quality indicators, and respond in real time to evolving evidence.
Driving Real-World Impact.
The value of Scite is exemplified through its application in live research workflows. One pharmaceutical company working on the experimental antidepressant NSI-189 had previously relied on slow, manual citation checks. By integrating Scite, the research team was able to instantly view how their work was cited across sixteen studies, analyze thirteen distinct citation statements, and understand the full context of each reference. This immediate insight enabled the team to pivot strategies and identify emerging directions while projects were still active, saving significant time and resources.
Similarly, biotechnology leader Natera integrated Scite across its scientific writing workflow, where specialized medical writers produce approximately forty papers annually. By eliminating hours of manual literature assessment, the team could surface relevant studies quickly, verify citations efficiently, and access reliable references for regulatory submissions and market intelligence. Clients report that these efficiencies have fundamentally transformed their approach to literature assessment, improving both speed and accuracy in high-stakes research.
Building Trust in AI-Driven Research.
As AI tools become increasingly prevalent in drug discovery, the challenge of trust and transparency grows. Research Solutions prioritizes the integrity of AI-driven insights. Third-party generative model partners do not use client data for training, users can control session storage, and the platform is designed to maintain strict compliance with regulatory standards. Researchers can always verify the underlying citation context, ensuring that AI-generated insights are transparent and reliable.
This commitment to trustworthy AI is particularly critical in pharmaceutical research, where inaccurate or misleading information can have real-world consequences. By anchoring AI outputs in peer-reviewed literature and contextual citation analysis, Scite provides the confidence pharmaceutical teams need to adopt AI tools safely and effectively.
Responding to Trends in Drug Discovery.
The convergence of AI and life sciences research is reshaping drug discovery. Organizations are increasingly relying on AI to accelerate clinical trial design, biomarker identification, and drug repurposing. Yet these opportunities come with complexity. Distributed teams, vast datasets, and collaborative platforms demand tools that combine scale with reliability. Scite addresses these needs by offering deep, publisher-independent access and contextual analysis, enabling researchers to synthesize evidence efficiently and responsibly.
Looking ahead, Scite is evolving to integrate API solutions that automate the identification and monitoring of drug targets, biomarkers, and compounds across entire research portfolios. This will allow pharmaceutical teams to conduct real-time literature synthesis, expand coverage to regulatory documents, and perform advanced pharmacovigilance monitoring. Over the next three to five years, Scite aims to evolve from a citation analysis tool into a research intelligence hub, seamlessly integrating with enterprise workflows to provide evidence-driven insights at unprecedented speed and scale.
Leadership Driving Innovation.
The leadership team at Research Solutions brings together deep scientific expertise and proven SaaS scaling experience. CEO Roy W. Olivier, with a track record of transforming technology companies and scaling SaaS solutions, leads the strategic vision. Chief Strategy Officer Josh Nicholson, PhD, co-founder of Scite, contributes scientific authority with his cell biology expertise and experience building research technology platforms. Together with CFO William Nurthen, CRO Sefton Cohen, CTO Rick Salloum, and CMO Corey Rabazinski, the executive suite combines business acumen, scientific credibility, and pharmaceutical market understanding to scale Research Solutions and Scite effectively across global research environments.
Awards and Industry Recognition.
Research Solutions’ innovative approach has earned significant industry recognition, including the ISMTE People’s Choice Award, the ALPSP Award for Innovation in Publishing, NSF and NIH/NIDA SBIR grants, the Vesalius Prize Runner-Up, and the 2025 Gold Award for Excellence in Publishing by the Society for Scholarly Publishing in the Hosting Platforms Feature category. These accolades reflect the company’s ongoing commitment to innovation, quality, and scientific integrity.
A Message to Pharma and Biotech Leaders.
In today’s research environment, AI tools are powerful but must be trusted. Scite exemplifies how responsible AI, grounded in verified scientific content, can transform workflows while safeguarding outcomes for patients, regulators, and researchers alike. By integrating contextual citation analysis into research strategy, pharmaceutical teams gain efficiency, transparency, and confidence,ensuring that every decision, from early discovery to clinical development, is informed by comprehensive and reliable evidence.
“Ultimately, Research Solutions and Scite represent more than tools,they embody a partnership for innovation. By bridging AI, data integrity, and scientific rigor, they empower organizations to accelerate drug discovery responsibly, turning complex data into actionable knowledge and meaningful patient impact.”
